Radiotherapy and immunotherapy converge on elimination of tumor-promoting erythroid progenitor cells through adaptive immunity

Author:

Hou Yuzhu12ORCID,Liang Hua L.2ORCID,Yu Xinshuang3ORCID,Liu Zhida4ORCID,Cao Xuezhi4ORCID,Rao Enyu5,Huang Xiaona2,Wang Liangliang2ORCID,Li Lei2,Bugno Jason6ORCID,Fu Yanbin2,Chmura Steven J.2ORCID,Wu Wenjun7,Luo Sean Z.8,Zheng Wenxin2,Arina Ainhoa2ORCID,Jutzy Jessica2ORCID,McCall Anne R.9ORCID,Vokes Everett E.10ORCID,Pitroda Sean P.2,Fu Yang-Xin4ORCID,Weichselbaum Ralph R.2ORCID

Affiliation:

1. Department of Pathogenic Microbiology and Immunology, School of Basic Medical Sciences, Xi’an Jiaotong University, Xi’an, ShaanXi 710061, China.

2. Ludwig Center for Metastasis Research, Department of Radiation and Cellular Oncology, University of Chicago, Chicago, IL 60637 USA.

3. Department of Oncology, First Affiliated Hospital of Shandong First Medical University and Shandong Provincial Qianfoshan Hospital, Jinan, Shandong 250014, China.

4. Department of Pathology, University of Texas Southwest Medical Center, Dallas, TX 75235, USA.

5. Cancer Institute, Xuzhou Medical University, Xuzhou, Jiangsu 221004, China.

6. Committee on Clinical Pharmacology and Pharmacogenomics, University of Chicago, Chicago, IL 60637, USA.

7. Fox Chase Cancer Center, Philadelphia, PA 19111, USA.

8. Whitney Young High School, Chicago, IL 60607, USA.

9. Radiation and Cellular Oncology, University of Chicago, Chicago, IL 60637, USA.

10. Department of Medicine, University of Chicago, Chicago, IL 60637, USA.

Abstract

Radiation and immunotherapy reduce tumor-induced erythroid progenitor cells, revealing possible targets for potentiating cancer therapies.

Funder

National Institutes of Health

Ludwig Institute for Cancer Research

National Natural Science Foundation of China

The Chicago Tumor Institute

Mr. & Mrs. Vincent Foglia

University of Chicago Cancer Center Support Grant

Clinical Therapeutics Training Grant

Young Talent Program of Xi’an Jiaotong University

Publisher

American Association for the Advancement of Science (AAAS)

Subject

General Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3